Page last updated: 2024-11-06

sulfamidochrysoidine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

sulfamidochrysoidine: RN given refers to parent cpd; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

prontosil : A diphenyldiazene compound having two amino substituents at the 2- and 4-positions and an aminosulphonyl substituent at the 4'-position. It was the first antibacterial drug, (introduced 1935) and the first of the sulfonamide antibiotics. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID66895
CHEMBL ID488279
CHEBI ID8464
SCHEMBL ID155099
SCHEMBL ID155098
MeSH IDM0044397

Synonyms (32)

Synonym
benzenesulfonamide,4-[2-(2,4-diaminophenyl)diazenyl]-
103-12-8
C07573
prontosil
sulfamidochrysoidine
4-[(2,4-diaminophenyl)diazenyl]benzenesulfonamide
rubiazol
p-((2,4-diaminophenyl)azo)benzenesulphonamide
CHEBI:8464 ,
aseptil rojo (tn)
D08542
CHEMBL488279
ai3-09088
benzenesulfonamide, 4-((2,4-diaminophenyl)azo)-
einecs 203-081-2
unii-q64q9n6q6o
q64q9n6q6o ,
sulfamidochrysoidine [who-dd]
sulfamidochrysoidine [mi]
benzenesulfonamide, 4-(2-(2,4-diaminophenyl)diazenyl)-
SCHEMBL155099
SCHEMBL155098
prontosil red
relbazon; streptocide; sulfamidochrysoidin
DTXSID60145608
p-[(2,4-diaminophenyl)azo]benzenesulphonamide
Q418758
4-(2,4-diaminophenyl)diazenylbenzenesulfonamide
gtpl12743
p-[(2,4-diaminophenyl)azo]benzene-sulfonamide
4-[(2,4-diaminophenyl)diazenyl]benzene-1-sulfonamide
DTXSID70871587
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID409954Inhibition of mouse brain MAOA2008Journal of medicinal chemistry, Nov-13, Volume: 51, Issue:21
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (55)

TimeframeStudies, This Drug (%)All Drugs %
pre-199038 (69.09)18.7374
1990's5 (9.09)18.2507
2000's8 (14.55)29.6817
2010's4 (7.27)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 19.43

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index19.43 (24.57)
Research Supply Index4.13 (2.92)
Research Growth Index4.26 (4.65)
Search Engine Demand Index18.60 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (19.43)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews4 (6.56%)6.00%
Case Studies5 (8.20%)4.05%
Observational0 (0.00%)0.25%
Other52 (85.25%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]